Vol. 83, Issue 1, 2020January 17, 2020 EDT
BANNING OFF-LABEL DRUG PROMOTION OFFENDS THE U.S. CONSTITUTION: MAKING THE STRONGEST CASE
BANNING OFF-LABEL DRUG PROMOTION OFFENDS THE U.S. CONSTITUTION: MAKING THE STRONGEST CASE
Lars Noah,
U.S. Food and Drug Administration“off-label” usesapproved therapeutic productsFirst Amendmentcommercial free speech principlesU.S. Supreme Courtbrand-name competitors
Lars Noah, BANNING OFF-LABEL DRUG PROMOTION OFFENDS THE U.S. CONSTITUTION: MAKING THE STRONGEST CASE, 83 Albany Law Review (2020).